Health Care & Life Sciences » Pharmaceuticals | Axsome Therapeutics Inc.

Axsome Therapeutics Inc.

Axsome Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$900.57 M
Shares Outstanding
33.28 M
Public Float
20.74 M


200 Broadway
New York New York 10038
United States
Employees -
Updated 07/08/2019
Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.


View All

Herriott Tabuteau
Chairman & Chief Executive Officer
Myrtle S. Potter
Independent Director